Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Iridian now a 14.2% owner.
http://d18rn0p25nwr6d.cloudfront.net/CIK-0001159036/52c07812-aa31-45e9-84e9-555c3d66221d.pdf

As of the date of this Statement, the Reporting Persons beneficially owned in the aggregate 18,426,928 shares of Common Stock which equates to approximately 14.2% of the outstanding shares (the percentage of shares of Common Stock owned being based upon 129,490.070 shares of Common Stock outstanding at November 1, 2016 as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2016).
Iridian has direct beneficial ownership of the shares of Common Stock in the accounts for which it serves as the investment adviser under its investment management agreements.
Messrs. Cohen and Levy may be deemed to possess beneficial ownership of the shares of Common Stock beneficially owned by Iridian by virtue of their indirect controlling ownership of Iridian, and having the power to vote and direct the disposition of shares of Common Stock as joint Chief Investment Officers of Iridian. Messrs. Cohen and Levy disclaim beneficial ownership of such shares.
As used herein, "beneficial ownership" has the meaning set forth in Rule 13d-3 under the Securities Exchange Act of 1934, as amended.